Lipella Pharmaceuticals Inc. (LIPO)
OTCMKTS · Delayed Price · Currency is USD
0.4700
-0.0200 (-4.08%)
Oct 29, 2025, 4:00 PM EDT

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Novel Therapeutics
536.36K
Log In
Log In
Log In
Log In
Upgrade
Novel Therapeutics Growth
19.29%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
536.36K
Log In
Log In
Log In
Log In
Upgrade
United States Growth
19.29%
Log In
Log In
Log In
Log In
Upgrade